Economic Outlook of 3D Cell Culture: Billions in Savings for Big Pharma
The financial burden of drug development is a major concern for the global pharmaceutical industry, with the cost of bringing a single drug to market often exceeding $2 billion. A significant portion of this cost is wasted on "false starts"—drugs that work in 2D cell cultures or animals but fail when they reach human subjects. This is where 3D cell culture offers a massive economic...
0 Reacties 0 aandelen 168 Views 0 voorbeeld